Table 1 Baseline characteristics of included patients undergoing VALS
Variables | POP patients (n = 106) |
|---|---|
Age, mean ± SD, years | 55.86 ± 8.48 |
BMI, mean ± SD, kg/m² | 24.10 ± 2.89 |
Gravidity, median (range) | 3 (1–8) |
Parity, median (range) | 2 (1–6) |
Menopause status, n (%) | 76 (71.7) |
Comorbidity, n (%) | |
Hypertension | 18 (16.98) |
Diabetes | 5 (4.72) |
Coronary heart disease | 3 (2.83) |
Hyperthyroidism | 2 (1.89) |
Hypothyroidism | 2 (1.89) |
Hysteromyoma | 26 (24.53) |
Stress urinary incontinence | 23 (21.70) |
Urgent urinary incontinence | 3 (2.83) |
Mixed urinary incontinence | 2 (1.89) |
Depression | 2 (1.89) |
Previous surgery history, n (%) | |
Tubal ligation | 18 (16.98) |
Cesarean delivery | 4 (3.77) |
Hysteromyomectomy | 2 (1.89) |
Pelvic reconstruction surgery | 4 (3.77) |
Vaginal repair | 3 (2.83) |
POP-Q stage, n (%) | |
III | 59 (55.66) |
IV | 47 (44.34) |
Follow-up period, median (range), months | 35.40 (12.13–109.97) |